X0202 SCHEDULE 13G 0001732374 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 07/23/2026 0001829635 TransCode Therapeutics, Inc. 89357L501 6 Liberty Square, #2382, Boston, MA 02109 Rule 13d-1(c) Unleash Immuno Oncolytics, Inc. b DE 300000.00 0.00 300000.00 0.00 300000.00 N 9.94 CO TransCode Therapeutics, Inc. 6 Liberty Square, #2382, Boston, Massachusetts, 02109 Unleash Immuno Oncolytics, Inc. 990 Biscayne Boulevard, Suite 502 Miami, FL 33132 Delaware Y 300,000 9.94% 300,000 0 300,000 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Unleash Immuno Oncolytics, Inc. /s/Daniel Eduardo Katzman 07/28/2026